99 related articles for article (PubMed ID: 15457669)
1. Quantitative microscopy of human DNA topoisomerase II-alpha expression in transitional cell carcinoma of the bladder.
Rath-Wolfson L; Hammel I; Kugel V; Leib Z; Dekel Y; Koren R
Anal Quant Cytol Histol; 2004 Aug; 26(4):181-6. PubMed ID: 15457669
[TBL] [Abstract][Full Text] [Related]
2. Human DNA topoisomerase-IIalpha expression as a prognostic factor for transitional cell carcinoma of the urinary bladder.
Koren R; Kugel V; Dekel Y; Weissman Y; Livne PM; Gal R
BJU Int; 2003 Apr; 91(6):489-92. PubMed ID: 12656900
[TBL] [Abstract][Full Text] [Related]
3. Elevations of DNA topoisomerase I in transitional cell carcinoma of the urinary bladder: correlation with DNA topoisomerase II-alpha and p53 expression.
Monnin KA; Bronstein IB; Gaffney DK; Holden JA
Hum Pathol; 1999 Apr; 30(4):384-91. PubMed ID: 10208458
[TBL] [Abstract][Full Text] [Related]
4. Utility of ProEx C in the histologic evaluation of the neoplastic and nonneoplastic urothelial lesions.
Moatamed NA; Vergara-Lluri ME; Lu D; Apple SK; Kerkoutian S; Rao JY
Hum Pathol; 2013 Nov; 44(11):2509-17. PubMed ID: 24029711
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of topoisomerase II alpha immunostaining in urothelial bladder carcinoma.
Nakopoulou L; Zervas A; Lazaris AC; Constantinides C; Stravodimos C; Davaris P; Dimopoulos C
J Clin Pathol; 2001 Apr; 54(4):309-13. PubMed ID: 11304849
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of DNA content in polyomavirus-infected urothelial cells, urothelial dysplasia and high grade transitional cell carcinoma.
Wojcik EM; Miller MC; Wright BC; Veltri RW; O'Dowd GJ
Anal Quant Cytol Histol; 1997 Oct; 19(5):430-6. PubMed ID: 9349903
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder.
Sumi T; Yoshida H; Hyun Y; Yasui T; Matsumoto Y; Hattori K; Sugimura K; Kawashima H; Nakatani T; Ishiko O
Oncol Rep; 2003; 10(2):345-9. PubMed ID: 12579270
[TBL] [Abstract][Full Text] [Related]
8. Histopathological and immunohistochemical study of papillary urothelial neoplasms of low malignant potential and grade associated with extensive invasive low-grade urothelial carcinoma.
Mai KT; Elmontaser G; Perkins DG; Yazdi HM; Stinson WA; Thijssen A
BJU Int; 2004 Sep; 94(4):544-7. PubMed ID: 15329109
[TBL] [Abstract][Full Text] [Related]
9. Expression of topoisomerase II alpha, ki67, and p53 in primary non-muscle-invasive urothelial bladder carcinoma.
Ben Abdelkrim S; Rammeh S; Ziadi S; Tlili T; Jaidane M; Mokni M
J Immunoassay Immunochem; 2014; 35(4):358-67. PubMed ID: 24624938
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor.
Tanoguchi K; Sasano H; Yabuki N; Kikuchi A; Ito K; Sato S; Yajima A
Mod Pathol; 1998 Feb; 11(2):186-93. PubMed ID: 9504690
[TBL] [Abstract][Full Text] [Related]
12. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
Lee DH; Yang SC; Hong SJ; Chung BH; Kim IY
Clin Cancer Res; 1998 Mar; 4(3):535-8. PubMed ID: 9533519
[TBL] [Abstract][Full Text] [Related]
13. Urothelial tumours of the urinary bladder: a histopathological study of cystoscopic biopsies.
Vaidya S; Lakhey M; K C S; Hirachand S
JNMA J Nepal Med Assoc; 2013; 52(191):475-8. PubMed ID: 24907954
[TBL] [Abstract][Full Text] [Related]
14. [The significance of the expression of cyclooxygenase-2 in bladder transitional cell carcinoma tissues].
Ren L; Hou SK; He LF; Ye HY; Guan KP
Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1104-7. PubMed ID: 15498296
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder.
Ristimäki A; Nieminen O; Saukkonen K; Hotakainen K; Nordling S; Haglund C
Am J Pathol; 2001 Mar; 158(3):849-53. PubMed ID: 11238034
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemistry of collagenase expression in transitional cell carcinoma of the bladder.
Hattori M; Ohno E; Kuramoto H
Acta Cytol; 2000; 44(5):771-7. PubMed ID: 11015978
[TBL] [Abstract][Full Text] [Related]
17. P53 overexpression in bladder urothelial neoplasms: new aspect of World Health Organization/International Society of Urological Pathology classification.
Kalantari MR; Ahmadnia H
Urol J; 2007; 4(4):230-3. PubMed ID: 18270948
[TBL] [Abstract][Full Text] [Related]
18. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
Zhan J; Tang XD
Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical positive stained p53 protein in bladder transitional cell carcinoma.
Halimi M; Salehi A; Baybordi H; Nezami N
Indian J Pathol Microbiol; 2009; 52(2):155-8. PubMed ID: 19332900
[TBL] [Abstract][Full Text] [Related]
20. The cytology of transitional cell carcinoma of the urinary bladder.
Kern WH
Acta Cytol; 1975; 19(5):420-8. PubMed ID: 1058612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
